To the best of investigators' knowledge, this is the first clinical trial conducted with adolescents diagnosed with anxiety/and or depressive disorders that tests the accuracy of a prediction model based on fMRI to investigate participants' response to a transdiagnostic Internet-delivered intervention.
Age
13–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
elevated symptoms of anxiety or depression/ internalizing problems (T score\> 60) at intake (based on Youth self-report completed by adolescents)
primary diagnosis of an anxiety/depressive disorder based on DSM-5 criteria according to ADIS-5-C/P interview
age 13-17
able to read and understand Romanian language
Currently unmedicated or on stable and adequate doses of medication for at least 6 weeks before treatment onset
Internet access
You may not be if
severe mental disorder (psychosis, severe depression, bipolar disorder, based on clinical interview)
any condition that interferes with the protocol implementation (e.g., physical illness or sensory impairment that interferes with behavioral tasks such as exposure, behavioral activation, unavailable for the next 3 months),
active suicidal ideation (assessed by child psychiatrist during clinical interview) in the last month
currently following CBT/ psychotherapy for anxiety/depression, in the last 6 months
fMRI incompatible (based on safety questionnaire)
Being diagnosed with an intellectual disability, pervasive developmental disorder, an alcohol and/or substance dependence disorder, reading disabilities (based on clinical interview).
Current treatment with benzodiazepines
Clareo Health | Transdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and Depression
